2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1103

Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia
Abstract Number: 585

Breast Cancer In Systemic Lupus (SLE): Do Demographic and Clinical Factors, Including DNA serology, Influence Risk?
Abstract Number: 245

C-Reactive Protein But Not Erythrocyte Sedimentation Rate Is Associated With Decrease In Muscle Strength In Patients With Knee Osteoarthritis: A 2 Year Follow Up Study
Abstract Number: 731

C3 Activation Is Associated With The Disease Activity Of Microscopic Polyangiitis
Abstract Number: 2567

Cadherin-11 Regulates Pulmonary Fibrosis In Bleomycin-Induced Lung Injury
Abstract Number: 2724

cAMP Responsive Element Modulator (CREM)α Governs CD8 Expression and Contributes to the Generation of CD3⁺CD4^–CD8^– T Cells in Lupus
Abstract Number: 2549

Can Biomarkers Provide An Objective Standard Against Which To Assess Lupus Clinical Endpoint Measures?
Abstract Number: 2581

Can Changes In NT-Probnp Predict Early Response To Therapy and Prognosis In Systemic Sclerosis Associated Pre-Capillary Pulmonary Hypertension?
Abstract Number: 188

Can MDHAQ/RAPID3 Be Used In Usual Care Of Patients With Systemic Lupus Erythematosus?
Abstract Number: 402

Can Modulators Of Inflammation Serve As Biomarkers For Subclinical Atherosclerosis In Rheumatoid Arthritis?
Abstract Number: 232

Can Musculoskeletal Ultrasonography Examination (MSUS) Predict Outcome In Shoulder Impingement Syndrome (SIS)? A Prospective Blinded Study
Abstract Number: 1708

Can People With Rheumatoid Arthritis Self Monitor Their Disease Activity?
Abstract Number: 2759

Can RA Registries Provide Contextual Safety Data For Modern RCTs?
Abstract Number: 192

Can Routine Assessment Of Patient Index Data (RAPID)3 Be Used As a Patient Reported Assessment Tool For Patients With Ankylosing Spondylitis?
Abstract Number: 1946

Can Satisfactory Reliability Of The 7-Joint Ultrasound Score Be Attained By Inexperienced Readers In a Single Calibration Exercise? Results From The Biodam Program

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].